BIOTECH INSIGHTS

FDA Approves Landmark COVID/Heart/CBD Clinical Trial

The US Food and Drug Administration (FDA) recently announced a potentially major development in the quest to improve outcomes for COVID-19 patients. The agency...

BIOTECH NEWS

Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis...

The first pharmaceutically produced THC-free* extra-strength cannabidiol (CBD) Oakville, Ontario--(Newsfile Corp. - October 20, 2020) -  Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the...

Cardiol Therapeutics Receives FDA Approval For Investigational New Drug (IND) Application...

Trial will take place at major U.S. centers and examine the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior...
Advertisement

CEO INTERVIEWS

BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.

In this episode of Biotech Stocktrader, we are joined by Dr. Nader Pourhassan, President and CEO of CytoDyn, a biotechnology company developing innovative treatments...

BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).

In this episode of BiotechStocktrader we are joined by Dr. Carl Schwartz, CEO of Precision Therapeutics, ticker AIPT. About Precision Therapeutics Inc. Precision Therapeutics (AIPT)...